Article Versions Notes

Bulitta JB, Jiao Y, Landersdorfer CB, Sutaria DS, Tao X, Shin E, Höhl R, Holzgrabe U, Stephan U, Sörgel F. Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics. 2019; 11(7):323. https://doi.org/10.3390/pharmaceutics11070323

Bulitta, Jürgen B., Yuanyuan Jiao, Cornelia B. Landersdorfer, Dhruvitkumar S. Sutaria, Xun Tao, Eunjeong Shin, Rainer Höhl, Ulrike Holzgrabe, Ulrich Stephan, and Fritz Sörgel. 2019. "Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics" Pharmaceutics 11, no. 7: 323. https://doi.org/10.3390/pharmaceutics11070323

Bulitta, J. B., Jiao, Y., Landersdorfer, C. B., Sutaria, D. S., Tao, X., Shin, E., Höhl, R., Holzgrabe, U., Stephan, U., & Sörgel, F. (2019). Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics, 11(7), 323. https://doi.org/10.3390/pharmaceutics11070323